{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T15:37:25Z","timestamp":1791733045160,"version":"4.3.4"},"reference-count":82,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T00:00:00Z","timestamp":1673740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Canine atopic dermatitis (CAD) is a common, chronic, inflammatory skin disease in dogs worldwide. This disease often predisposes for secondary organisms overgrowth and skin infections with pathogens, such as Staphylococcus pseudintermedius and Malassezia pachydermatis. Unfortunately, the causes of this disease in both humans and animals are not fully understood; therefore, the only possible option is a lifelong, symptomatic treatment. The management of CAD is mainly based on limiting contact with allergens and antipruritic therapy, most often with glucocorticoids and antihistamines. A serious problem in this situation is the fact, that long-term administration of glucocorticoids leads to side effects like polyuria, alopecia, increased susceptibility to infection, muscle atrophy, and many others. For this reason, great emphasis is placed on the development of replacement and supportive therapies. It is a well-documented fact that reduced concentrations of serum vitamin D3 contribute to the severity of atopic dermatitis symptoms in humans. Moreover, unlike the most commonly used therapeutic methods, of which the main goal is to ameliorate inflammation and pruritus, namely the symptoms of AD, vitamin D3 supplementation affects some underlying factors of this disease. Therefore, in this review, we summarize the current state of knowledge regarding the role of vitamin D3 in CAD, its protective effect against secondary bacterial and fungal infections, and the potential of its supplementation in dogs.<\/jats:p>","DOI":"10.3390\/pathogens12010145","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T01:31:15Z","timestamp":1673832675000},"page":"145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Is Vitamin D3 a Worthy Supplement Protecting against Secondary Infections in Dogs with Atopic Dermatitis?"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4308-4155","authenticated-orcid":false,"given":"Dorota","family":"Chrobak-Chmiel","sequence":"first","affiliation":[{"name":"Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Golke","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Kwiecie\u0144","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata J.","family":"Biega\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourou","family":"Dembele","sequence":"additional","affiliation":[{"name":"Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 159c, 02-776 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Dziekiewicz-Mrugasiewicz","sequence":"additional","affiliation":[{"name":"Department of Large Animal Diseases with Clinic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 100, 02-797 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4238-8360","authenticated-orcid":false,"given":"Micha\u0142","family":"Czopowicz","sequence":"additional","affiliation":[{"name":"Division of Veterinary Epidemiology and Economics, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 159c, 02-776 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kizerwetter-\u015awida","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4306-0575","authenticated-orcid":false,"given":"Magdalena","family":"Rzewuska","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hensel, P., Santoro, D., Favrot, C., Hill, P., and Griffin, C. (2015). Canine atopic dermatitis: Detailed guidelines for diagnosis and allergen identification. BMC Vet. Res., 11.","DOI":"10.1186\/s12917-015-0515-5"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"84.e25","DOI":"10.1111\/vde.12197","article-title":"Review: Pathogenesis of canine atopic dermatitis: Skin barrier and host-microorganism interaction","volume":"26","author":"Santoro","year":"2015","journal-title":"Vet. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13601-018-0228-5","article-title":"Atopic dermatitis in cats and dogs: A difficult disease for animals and owners","volume":"8","author":"Gedon","year":"2018","journal-title":"Clin. Transl. Allergy"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100519","DOI":"10.1016\/j.waojou.2021.100519","article-title":"Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence","volume":"14","author":"Wollenberg","year":"2021","journal-title":"World Allergy Organ J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-2222.2002.01356.x","article-title":"Expression of Th1, Th2 and immunosuppressive cytokine gene transcripts in canine atopic dermatitis","volume":"32","author":"Nuttall","year":"2002","journal-title":"Clin. Exp. Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"48.e12","DOI":"10.1111\/j.1365-3164.2012.01098.x","article-title":"Interleukin-31: Its role in canine pruritus and naturally occurring canine atopic dermatitis","volume":"24","author":"Gonzales","year":"2013","journal-title":"Vet. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1067\/mai.2000.106484","article-title":"Atopic dermatitis: New insights and opportunities for therapeutic intervention","volume":"105","author":"Leung","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0165-2427(02)00066-1","article-title":"Immune dysregulation in atopic dermatitis","volume":"87","author":"Sinke","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Majewska, A., Gajewska, M., Dembele, K., Maciejewski, H., Prostek, A., and Jank, M. (2016). Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis. BMC Vet. Res., 12.","DOI":"10.1186\/s12917-016-0805-6"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/1348-0421.12650","article-title":"IL-4 dysregulates microRNAs involved in inflammation, angiogenesis and apoptosis in epidermal keratinocytes","volume":"62","author":"Bao","year":"2018","journal-title":"Microbiol. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cvsm.2018.08.002","article-title":"Therapies in canine atopic dermatitis: An update","volume":"49","author":"Santoro","year":"2019","journal-title":"Vet. Clin. Small Anim."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-3164.2009.00845.x","article-title":"Breed and site predispositions of dogs with atopic dermatitis: A comparison of five locations in three continents","volume":"21","author":"Jaeger","year":"2010","journal-title":"Vet. Dermatol."},{"key":"ref_13","unstructured":"Favrot, C. (2015, January 26\u201327). Clinical signs and diagnosis of canine atopic dermatitis. Proceedings of the 3 Congresso Latinoamericano de Dermatologia Veterinaria, Buenos Aires, Argentina."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2460\/javma.254.11.1291","article-title":"Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs","volume":"254","author":"Nuttall","year":"2019","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yasa.2021.07.004","article-title":"Current knowledge on canine atopic dermatitis: Pathogenesis and treatment","volume":"2","author":"Outerbridge","year":"2021","journal-title":"Adv. Small Anim. Care"},{"key":"ref_16","first-page":"414","article-title":"Treatment of canine atopic dermatitis with cetirizine, a second generation antihistamine: A single-blinded, placebo-controlled study","volume":"45","author":"Cook","year":"2004","journal-title":"Can. Vet. J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Olivry, T., DeBoer, D.J., Favrot, C., Jackson, H.A., Mueller, R.S., Nuttall, T., and Pr\u00e9laud, P. (2015). International Committee on Allergic Diseases of Animals. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA). BMC Vet. Res., 11.","DOI":"10.1186\/s12917-015-0514-6"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tvjl.2015.09.016","article-title":"An update on the treatment of canine atopic dermatitis","volume":"207","author":"Saridomichelakis","year":"2016","journal-title":"Vet. J."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Marsella, R. (2021). Atopic dermatitis in domestic animals: What our current understanding is and how this applies to clinical practice. Vet. Sci., 8.","DOI":"10.3390\/vetsci8070124"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bruet, V., Mosca, M., Briand, A., Bourdeau, P., Pin, D., Cochet-Faivre, N., and Cadiergues, M.C. (2022). Clinical guidelines for the use of antipruritic drugs in the control of the most frequent pruritic skin diseases in dogs. Vet. Sci., 9.","DOI":"10.3390\/vetsci9040149"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/vr.106024","article-title":"Allergen-specific immunotherapy in dogs with atopic dermatitis: Is owner compliance the main success-limiting factor?","volume":"187","author":"Ferrer","year":"2020","journal-title":"Vet. Rec."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/jvp.12101","article-title":"Oclacitinib (Apoquel\u00ae) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy","volume":"37","author":"Gonzales","year":"2014","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"587.e142","DOI":"10.1111\/vde.12088","article-title":"A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel\u00ae) in client-owned dogs with atopic dermatitis","volume":"24","author":"Cosgrove","year":"2013","journal-title":"Vet. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"23.e8","DOI":"10.1111\/vde.12186","article-title":"A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs","volume":"26","author":"Little","year":"2015","journal-title":"Vet. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"22.e7","DOI":"10.1111\/vde.12278","article-title":"Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks","volume":"27","author":"Panteri","year":"2016","journal-title":"Vet. Dermatol."},{"key":"ref_26","first-page":"477.e131","article-title":"A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client-owned dogs with allergic dermatitis","volume":"32","author":"Brussel","year":"2021","journal-title":"Vet. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"593.e145","DOI":"10.1111\/vde.12478","article-title":"A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis","volume":"28","author":"Moyaert","year":"2017","journal-title":"Vet. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.17555\/jvc.2021.38.3.127","article-title":"Clinical efficacy of oclacitinib and lokivetmab in dogs with canine atopic dermatitis","volume":"38","author":"Lee","year":"2021","journal-title":"J. Vet. Clin."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-3164.2009.00745.x","article-title":"Staphylococcal colonization of mucosal and lesional skin sites in atopic and healthy dogs","volume":"20","author":"Fazakerley","year":"2009","journal-title":"Vet. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rodrigues-Hoffmann, A., Patterson, A.P., Diesel, A., Lawhon, S.D., Ly, H.J., Stephenson, C.E., Mansell, J., Steiner, J.M., Dowd, S.E., and Olivry, T. (2014). The skin microbiome in healthy and allergic dogs. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0083197"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"fiv139","DOI":"10.1093\/femsec\/fiv139","article-title":"What is living on your dog\u2019s skin? Characterization of the canine cutaneous mycobiota and fungal dysbiosis in canine allergic dermatitis","volume":"91","author":"Diesel","year":"2015","journal-title":"FEMS Microbiol. Ecol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/vde.12366","article-title":"The skin microbiome in allergen-induced canine atopic dermatitis","volume":"27","author":"Pierezan","year":"2016","journal-title":"Vet. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7717\/peerj.3075","article-title":"Diverse bacterial communities exist on canine skin and are impacted by cohabitation and time","volume":"5","author":"Torres","year":"2017","journal-title":"Peer J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"184.e46","DOI":"10.1111\/vde.12301","article-title":"Transcription of thymic stromal lymphopoietin via Toll-like receptor 2 in canine keratinocytes: A possible association of Staphylococcus spp. in the deterioration of allergic inflammation in canine atopic dermatitis","volume":"27","author":"Sakamoto","year":"2016","journal-title":"Vet. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jid.2016.01.023","article-title":"Longitudinal evaluation of the skin microbiome and association with microenvironment and treatment in canine atopic dermatitis","volume":"136","author":"Bradley","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Older, C.E., Rodrigues-Hoffmann, A., Hoover, K., and Banovic, F. (2020). Characterization of cutaneous bacterial microbiota from superficial pyoderma forms in atopic dogs. Pathogens, 9.","DOI":"10.3390\/pathogens9080638"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sofou, E.I., Aleksandrova, S., Badulescu, E., Chatzis, M., and Saridomichelakis, M. (2022). Efficacy of antimicrobial treatment in dogs with atopic dermatitis: An observational study. Vet. Sci., 9.","DOI":"10.3390\/vetsci9080385"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-3164.2005.00463.x","article-title":"Humoral measurement of type-1 hypersensitivity reactions to a commercial Malassezia allergen","volume":"16","author":"Farver","year":"2005","journal-title":"Vet. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.molimm.2009.05.028","article-title":"Altered cutaneous expression of \u03b2-defensins in dogs with atopic dermatitis","volume":"46","author":"Willemse","year":"2009","journal-title":"Mol. Imm."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Coates, M., Blanchard, S., and MacLeod, A.S. (2018). Innate antimicrobial immunity in the skin: A protective barrier against bacteria, viruses, and fungi. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007353"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaci.2008.03.027","article-title":"Antimicrobial peptides and the skin immune defense system","volume":"122","author":"Schauber","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"39.e10","DOI":"10.1111\/j.1365-3164.2012.01091.x","article-title":"Evaluation of canine antimicrobial peptides in infected and noninfected chronic atopic skin","volume":"24","author":"Santoro","year":"2013","journal-title":"Vet. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"177.e36","DOI":"10.1111\/j.1365-3164.2012.01037.x","article-title":"Antimicrobial peptides: Agents of border protection for companion animals","volume":"23","author":"Leonard","year":"2012","journal-title":"Vet. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"402.e132","DOI":"10.1111\/vde.12661","article-title":"Evaluation of the secretion of antimicrobial peptides and antimicrobial effect of skin wash in atopic and healthy dogs: A preliminary study","volume":"29","author":"Santoro","year":"2018","journal-title":"Vet. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nri1180","article-title":"Defensins: Antimicrobial peptides of innate immunity","volume":"3","author":"Ganz","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MOH.0000000000000005","article-title":"Defensins in innate immunity","volume":"21","author":"Zhao","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1152\/physiolgenomics.00104.2005","article-title":"Cross-species analysis of the mammalian beta-defensin gene family: Presence of syntenic gene clusters and preferential expression in the male reproductive tract","volume":"23","author":"Patil","year":"2005","journal-title":"Physiol. Genom."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.4049\/jimmunol.179.11.7684","article-title":"Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways","volume":"179","author":"Yu","year":"2007","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15258","DOI":"10.1074\/jbc.272.24.15258","article-title":"The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders","volume":"272","author":"Frohm","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1074\/jbc.M008557200","article-title":"Isolation and characterization of human \u03b2-defensin-3, a novel human inducible peptide antibiotic","volume":"276","author":"Harder","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-2427(02)00140-X","article-title":"Lesional expression of thymus and activation-regulated chemokine in canine atopic dermatitis","volume":"88","author":"Maeda","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0165-2427(02)00076-4","article-title":"T-helper 1, T-helper 2 and immunosuppressive cytokines in canine atopic dermatitis","volume":"87","author":"Nuttall","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000334566","article-title":"Activity, expression and genetic variation of canine \u03b2-defensin 103: A multifunctional antimicrobial peptide in the skin of domestic dogs","volume":"4","author":"Leonard","year":"2012","journal-title":"J. Innate Immun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.4049\/jimmunol.173.5.2909","article-title":"Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression","volume":"173","author":"Wang","year":"2004","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40257-017-0323-8","article-title":"Vitamin D and the skin: An update for dermatologists","volume":"19","author":"Kechichian","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_58","unstructured":"Hand, M.S., Thatcher, C.D., Remillard, R.L., and Roudebush, P. (2000). Nutrients. Small Animal Clinical Nutrition, Mark Morris Institute. [4th ed.]."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1529-8019.2009.01287.x","article-title":"Vitamin D and innate immunity","volume":"23","author":"Miller","year":"2010","journal-title":"Dermatol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"White, J.H. (2022). Emerging roles of vitamin D-induced antimicrobial peptides in antiviral innate immunity. Nutrients, 14.","DOI":"10.3390\/nu14020284"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","article-title":"Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts","volume":"97","author":"Mathieu","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.4049\/jimmunol.150.8.3487","article-title":"Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells","volume":"150","author":"Oberg","year":"1993","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI30142","article-title":"Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism","volume":"117","author":"Schauber","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1074\/jbc.C109.071225","article-title":"Direct and indirect induction by 1,25-Dihydroxyvitamin D3 of the NOD2\/CARD15-defensin \u03b22 innate immune pathway defective in Crohn Disease","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Verway, M., Bouttier, M., Wang, T.T., Carrier, M., Calderon, M., An, B.S., Devemy, E., McIntosh, F., Divangahi, M., and Behr, M.A. (2013). Vitamin D induces interleukin-1\u03b2 expression: Paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003407"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1096\/fj.04-3284com","article-title":"Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3","volume":"19","author":"Gombart","year":"2005","journal-title":"FASEB J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2567.2006.02399.x","article-title":"Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli","volume":"118","author":"Schauber","year":"2006","journal-title":"Immunology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/jid.2008.35","article-title":"Vitamin D regulation of cathelicidin in the skin: Toward a renaissance of vitamin D in dermatology?","volume":"128","author":"Segaert","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.179.4.2060","article-title":"Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin","volume":"179","author":"Liu","year":"2007","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40257-022-00677-0","article-title":"Effect of vitamin D serum levels and supplementation on atopic dermatitis: A systematic review and meta-analysis","volume":"23","author":"Ng","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4168\/aair.2013.5.4.207","article-title":"Correlation between serum vitamin D level and the severity of atopic dermatitis associated with food sensitization","volume":"5","author":"Lee","year":"2013","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.aller.2017.12.004","article-title":"Is vitamin D level associated with the natural course of atopic dermatitis?","volume":"46","author":"Dogru","year":"2018","journal-title":"Allergol. Immunopathol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Hattangdi-Haridas, S.R., Lanham-New, S.A., Wong, W.H.S., Ho, M.H.K., and Darling, A.L. (2019). Vitamin D deficiency and effects of vitamin D supplementation on disease severity in patients with atopic dermatitis: A systematic review and meta-analysis in adults and children. Nutrients, 11.","DOI":"10.3390\/nu11081854"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e00679","DOI":"10.1002\/prp2.679","article-title":"The impact of vitamin D supplementation as an adjuvant therapy on clinical outcomes in patients with severe atopic dermatitis: A randomized controlled trial","volume":"8","author":"Mansour","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/vr.104492","article-title":"Vitamin D shows in vivo efficacy in a placebo-controlled, double-blinded, randomised clinical trial on canine atopic dermatitis","volume":"182","author":"Klinger","year":"2018","journal-title":"Vet. Rec."},{"key":"ref_77","first-page":"334","article-title":"Hypercalcaemia in two dogs caused by excessive dietary supplementation of vitamin D","volume":"46","author":"Mellanby","year":"2005","journal-title":"JSAP"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clim.2009.06.011","article-title":"Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells","volume":"133","year":"2009","journal-title":"Clin. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0149-2918(00)88299-5","article-title":"Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis","volume":"21","author":"Goldenberg","year":"1999","journal-title":"Clin. Ther."},{"key":"ref_80","first-page":"581","article-title":"Calcipotriol toxicity in a dog","volume":"39","author":"Fan","year":"1998","journal-title":"JSAP"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1354\/vp.37-5-490","article-title":"Metastatic calcification in a dog attributable to ingestion of a tacalcitol ointment","volume":"37","author":"Hilbe","year":"2000","journal-title":"Vet. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ced.14499","article-title":"Prevalence of vitamin D analogue toxicity in dogs","volume":"46","author":"Ho","year":"2021","journal-title":"Clin. Exp. Dermatol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/1\/145\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:06:31Z","timestamp":1760119591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/1\/145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,15]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["pathogens12010145"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12010145","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,15]]}}}